Results 311 to 320 of about 1,044,728 (382)

Mapping between clinical and preclinical terminologies: eTRANSAFE's Rosetta stone approach. [PDF]

J Biomed Semantics
van Mulligen EM, Parry R, van der Lei J, Kors JA.   +3 more
europepmc   +1 more source

Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models

S. Ryu, Hoe Suk Kim, Sangeun Lee, So-Hyun Yoon, Moonjou Baek, Adam Park, Han‐Byoel Lee, Ga Yeon Kim, K. Park, Ji-Jung Jung, Yireh Han, Dong Woo Lee, Bosung Ku, Wonshik Han   +13 more
openalex   +1 more source

Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer. [PDF]

BMC Pharmacol Toxicol
Irham LM, Adikusuma W, Afief AR, Khairi S, Chong R, Mufidah S, Satria RD, Mugiyanto E, Darmawi D, Amukti DP, Wirsahada BC, Philothra PT, Jaya I.   +12 more
europepmc   +1 more source

Utility of 131I-HLX58-Der for the Precision Treatment: Evaluation of a Preclinical Radio-Antibody-Drug-Conjugate Approach in Mouse Models

Yi Liu, Xiao Wang, Ni Zhang, Simin He, Jianping Zhang, Xiaoping Xu, Shaoli Song   +6 more
openalex   +1 more source

Approaches to modeling cancer metastasis: from bench to bedside. [PDF]

Front Oncol
Sun L, Zhou Y, Yin M, Wang F, Yang L.
europepmc   +1 more source

11P Preclinical evaluation of an anti-transferrin receptor antibody drug conjugate targeting triple-negative breast cancer

Pierre Launay
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Technological Advances in Preclinical Drug Evaluation: the Role of -Omics Methods.

Current Medicinal Chemistry, 2020
Preclinical drug development is an essential step in the drug development process where evaluation of new chemical entities occurs. In particular, preclinical drug development phases include deep analysis of drug candidates' interactions with ...
S. K. Pavelić, Elitza Markova-Car, M. Klobučar, Lana Sappe, R. Spaventi   +4 more
semanticscholar   +5 more sources

Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages.

European Journal of Cancer, 2004
Considering the enormous effort that has taken place over the years to discover new chemotherapeutic drugs for treating the common cancers, the conventional murine and xenograft test systems used to test efficacy for drug development have identified only a limited number of useful agents that are active clinically at well tolerated doses.
M. Bibby
semanticscholar   +4 more sources